Top Tweets for #ocvc

Atsushi Kikuchi @ak_cardiol

6 months ago

🫀News from OCVC arrhythmia investigators🫀 🇯🇵Sunaga et al. (Osaka Univ.) report SUPPRESS-AF subanalysis🇯🇵 📊LVA ablation追加はAF再発抑制の可能性も、死亡・脳梗塞など含めたhierarchical outcomesは改善せず📊 🔗https://t.co/QoMBHvW66K🔗 #AF #EP #OCVC

OCVC_lab's tweet photo. 🫀News from OCVC arrhythmia investigators🫀
🇯🇵Sunaga et al. (Osaka Univ.) report SUPPRESS-AF subanalysis🇯🇵
📊LVA ablation追加はAF再発抑制の可能性も、死亡・脳梗塞など含めたhierarchical outcomesは改善せず📊
🔗https://t.co/QoMBHvW66K🔗 #AF #EP #OCVC https://t.co/5Cx0thDdmR

0

3

2

0

510

7 months ago

倉敷の裏ですが、大阪でも阪大関連病院の虚血・SHD領域の先生が集まって、ライブ・研究発表・症例ディスカッションを２日にわたって行っています。このチームはやっぱりすごいと身内ながら思います👍 特に若手の勢いすごい👏 #OCVC #IIClive

0

20

1

0

2K

11 months ago

🫀 News from OCVC arrhythmia investigators ✨ 🔬 Led by Masaharu Masuda (Kansai Rosai Hospital), a SUPPRESS-AF subanalysis shows LVA ablation + PVI helps when LAD>44 mm, but not when LAD≤44 mm 📊 🔗 https://t.co/G2Beg9foJa #AFib #EP #OCVC #CirCEP 🚀

OCVC_lab's tweet photo. 🫀 News from OCVC arrhythmia investigators ✨
🔬 Led by Masaharu Masuda (Kansai Rosai Hospital), a SUPPRESS-AF subanalysis shows LVA ablation + PVI helps when LAD>44 mm, but not when LAD≤44 mm 📊
🔗 https://t.co/G2Beg9foJa #AFib #EP #OCVC #CirCEP 🚀 https://t.co/y76LwwPitn

0

4

1

0

269

about 1 year ago

ESC2025から無事日本に帰国しました。✈️🇯🇵 桜橋の不整脈科から4人(5演題)発表してきました。短時間ですが、座長・audienceの先生方とdiscussionできるのはESCならではの魅力だと改めて感じました。✨ ESCで発表した皆様。次は論文頑張りましょう！！（自分も含めて。。。）＃ESCCongress ＃OCVC

MasatoOkada1105's tweet photo. ESC2025から無事日本に帰国しました。✈️🇯🇵
桜橋の不整脈科から4人(5演題)発表してきました。
短時間ですが、座長・audienceの先生方とdiscussionできるのはESCならではの魅力だと改めて感じました。✨

ESCで発表した皆様。
次は論文頑張りましょう！！（自分も含めて。。。）

＃ESCCongress ＃OCVC https://t.co/hTv0LGRPjJ

0

36

3

0

4K

about 1 year ago

✨ News from the #OCVC arrhythmia team! 🧑‍⚕️ Dr. Akihiro Sunaga (The Univ of Osaka) 🫀 #AF patients with left atrial thrombus (#LAT N=260): DOAC vs warfarin 💊 Standard-dose DOACs outperformed warfarin with good TTR in terms of LAT resolution (74% vs 54%) 🔗https://t.co/YBbuzS2ufu

OCVC_lab's tweet photo. ✨ News from the #OCVC arrhythmia team!
🧑‍⚕️ Dr. Akihiro Sunaga (The Univ of Osaka)
🫀 #AF patients with left atrial thrombus (#LAT N=260): DOAC vs warfarin
💊 Standard-dose DOACs outperformed warfarin with good TTR in terms of LAT resolution (74% vs 54%)
🔗https://t.co/YBbuzS2ufu https://t.co/PhM7NgVkqn

0

7

2

386

about 1 year ago

✨News from the #OCVC ischemia investigators! 🩺 Sho Nakao (Kansai Rosai Hospital) 🛠️ Long-term outcomes after #ACS in #hemodialysis patients from the LONG-ST registry ⚠️ #StentThrombosis-related ACS in HD patients: 82% MACE, 70% mortality at 6 years 🔗https://t.co/b5xIoEyGLa

OCVC_lab's tweet photo. ✨News from the #OCVC ischemia investigators!
🩺 Sho Nakao (Kansai Rosai Hospital)
🛠️ Long-term outcomes after #ACS in #hemodialysis patients from the LONG-ST registry
⚠️ #StentThrombosis-related ACS in HD patients: 82% MACE, 70% mortality at 6 years
🔗https://t.co/b5xIoEyGLa https://t.co/4jbzgcgGS2

0

7

2

0

352

over 1 year ago

@Koichi16423232 @Yasuharu_ML Thank you Dr. Matsunaga and Dr. Nagashima for highlighting this study! 🙇‍♂️ I'm always inspired by your deep insights on EP.✨ #EPeeps #EP大学 #OCVC

0

9

1

445

over 1 year ago

Outstanding trial!!👏 Previous LVA ablation RCTs allocated patients before mapping, leading to mixed cohorts.👨‍👩‍👧 The SUPPRESS-AF trial correctly randomized patients with LVAs (<0.5mV and >5cm²) after mapping.😇 It was an honor to participate in this study. #OCVC @masudamasaha

MasatoOkada1105's tweet photo. Outstanding trial!!👏
Previous LVA ablation RCTs allocated patients before mapping, leading to mixed cohorts.👨‍👩‍👧
The SUPPRESS-AF trial correctly randomized patients with LVAs (<0.5mV and >5cm²) after mapping.😇
It was an honor to participate in this study.
#OCVC @masudamasaha https://t.co/sufzQKj3W6

over 1 year ago

✨New report in Nature Medicine from the OCVC arrhythmia investigators! 🎉Dr. Masaharu Masuda (Kansai Rosai Hospital) ⚡️LVA ablation in addition to PVI — does it change the game in persistent AF? 📊 The SUPPRESS-AF trial has the answer. 🔗 https://t.co/PHhqbhG9y3 #NatureMedicine

0

23

7

4

10K

0

15

4

2

2K

over 1 year ago

✨ New report from the OCVC Heart Failure investigators! ✨ Exploring the unique characteristics of young HFpEF patients! 💡 👨‍⚕️ Dr. Masami Nishino (Osaka Rosai Hospital) 👉 Read more: https://t.co/SHYUVuIgal #HFpEF #HeartFailure #Cardiology #MedicalResearch #OCVC

0

3

2

0

401

over 1 year ago

🚀New report from the OCVC ischemia/SHD investigators! ✨ Design paper of the OCVC-BIF trial (Prospective RCT) 📎Dr. Tomoharu Dohi (大阪大学)&Dr. Takayuki Ishihara (関西労災病院) 🩺 分岐部病変に対するDCBの効果を検証本試験の結果は今年発表を予定❗ #OCVC https://t.co/GIZrnIjLnu

OCVC_lab's tweet photo. 🚀New report from the OCVC ischemia/SHD investigators!
✨ Design paper of the OCVC-BIF trial (Prospective RCT)
📎Dr. Tomoharu Dohi (大阪大学)&Dr. Takayuki Ishihara (関西労災病院)
🩺 分岐部病変に対するDCBの効果を検証
本試験の結果は今年発表を予定❗
#OCVC
https://t.co/GIZrnIjLnu https://t.co/koJ3qT57oI

0

7

2

0

1K

over 1 year ago

📢 NT-proBNP isn’t one-size-fits-all — ✨ Optimal prognostic thresholds differ in the presence of comorbid AF, CKD, and more. 📊 Check out our latest work from the OCVC-HF team, Dr. Daisuke Sakamoto (Osaka University) 🔍 🔗https://t.co/Gf7MzYvLYW #HFpEF #NTproBNP #OCVC

OCVC_lab's tweet photo. 📢 NT-proBNP isn’t one-size-fits-all —
✨ Optimal prognostic thresholds differ in the presence of comorbid AF, CKD, and more.
📊 Check out our latest work from the OCVC-HF team, Dr. Daisuke Sakamoto (Osaka University) 🔍
🔗https://t.co/Gf7MzYvLYW
#HFpEF #NTproBNP #OCVC https://t.co/1GSM1Rq7Fv

0

9

1

519

over 1 year ago

🚨【速報】OCVC-HF investigatorsより📢 #JCS2025 の Late Breaking Clinical Trial Session にて、 MONACO trial の結果を中川彰人先生よりご発表いただきました✨📉結果はNegativeでしたが、科学的に非常に意義のある重要な知見です🔍🧠 詳細は📄Publishされ次第是非ご一読ください！📚💡 #OCVC

OCVC_lab's tweet photo. 🚨【速報】OCVC-HF investigatorsより📢
#JCS2025 の Late Breaking Clinical Trial Session にて、
MONACO trial の結果を中川彰人先生よりご発表いただきました✨📉結果はNegativeでしたが、科学的に非常に意義のある重要な知見です🔍🧠
詳細は📄Publishされ次第是非ご一読ください！📚💡
#OCVC https://t.co/YTEwmoqYDO

0

22

4

0

1K

over 1 year ago

Thank you for referring to my paper. 🙇‍♂️ Based on 17,436 TEE data, this study demonstrated reduced LA appendage flow velocity (<20 cm/s) at baseline was associated with unsuccessful LA thrombi resolution, occurrence of thromboembolism, or surgical removal.✨ #OCVC #EPeeps

over 1 year ago

Report from OCVC Arrhythmia investigators LAT registry @MasatoOkada1105 (Sakurabashi Watanabe Hospital) Impact of left atrial appendage flow velocity on thrombus resolution and clinical outcomes in patients with AF and silent left atrial thrombi https://t.co/xd784kGxyh

OCVC_lab's tweet photo. Report from OCVC Arrhythmia investigators
LAT registry
@MasatoOkada1105 (Sakurabashi Watanabe Hospital)
Impact of left atrial appendage flow velocity on thrombus resolution and clinical outcomes in patients with AF and silent left atrial thrombi
https://t.co/xd784kGxyh https://t.co/TQaIsqMrrl

0

5

1

2

2K

0

9

3

1

2K

about 2 years ago

Excellent presentation and discussion! In the SUPPRESS-AF trial, LVA ablation in addition to PVI did not prove significant efficacy in patients with persistent AF. However, potential efficacy was suggested in patients with advanced LA remodeling. #ESCCongress #OCVC @masudamasaha

MasatoOkada1105's tweet photo. Excellent presentation and discussion!
In the SUPPRESS-AF trial, LVA ablation in addition to PVI did not prove significant efficacy in patients with persistent AF. However, potential efficacy was suggested in patients with advanced LA remodeling.
#ESCCongress #OCVC @masudamasaha https://t.co/wHTZlO6snx

0

28

5

1

3K

over 2 years ago

We are pleased to publish a new evidence. 😃 Failed LA thrombus resolution was not rare in patients with AF and silent LA thrombi. Reduced LAA flow velocity (<20 cm/s) was associated with failed resolution and adverse outcomes.🚩 #Europace #EPeeps #OCVC https://t.co/4nIyQSHrxe

MasatoOkada1105's tweet photo. We are pleased to publish a new evidence. 😃
Failed LA thrombus resolution was not rare in patients with AF and silent LA thrombi. Reduced LAA flow velocity (<20 cm/s) was associated with failed resolution and adverse outcomes.🚩
#Europace #EPeeps #OCVC
https://t.co/4nIyQSHrxe https://t.co/zlQU8S2uJa

2

27

6

4

2K

about 3 years ago

New paper from the EARNEST-PVI trial(PVI alone vs. PVI-plus). Performing linear ablation in addition to PVI can decrease the likelihood of recurring AF/AT, but it may also raise the risk of iatrogenic ATs. #OCVC @masudamasaha https://t.co/2wxYKVuGyw

MasatoOkada1105's tweet photo. New paper from the EARNEST-PVI trial(PVI alone vs. PVI-plus). Performing linear ablation in addition to PVI can decrease the likelihood of recurring AF/AT, but it may also raise the risk of iatrogenic ATs.
#OCVC @masudamasaha
https://t.co/2wxYKVuGyw https://t.co/w6Y8cXH3H1

0

25

5

3

1K